Relagesic Interactions
There are 390 drugs known to interact with Relagesic (acetaminophen / phenyltoloxamine), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 17 are major, 357 are moderate, and 16 are minor.
- View all 390 medications that may interact with Relagesic
- View Relagesic alcohol/food interactions (1)
- View Relagesic disease interactions (7)
Most frequently checked interactions
View interaction reports for Relagesic (acetaminophen / phenyltoloxamine) and the medicines listed below.
- acetaminophen
- acetaminophen / guaifenesin / phenylephrine
- Afrin NoDrip Sinus (oxymetazoline nasal)
- albuterol
- Allegra (fexofenadine)
- Ambien (zolpidem)
- Antivert (meclizine)
- Asacol (mesalamine)
- aspirin
- Atarax (hydroxyzine)
- Atrovent HFA (ipratropium)
- baclofen
- Beano (alpha-d-galactosidase)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- biotin
- budesonide
- Cardizem (diltiazem)
- Cataflam (diclofenac)
- Catapres (clonidine)
- Demerol (meperidine)
- Depakote (divalproex sodium)
- Dramamine (dimenhydrinate)
- Dulcolax (bisacodyl)
- Endocet (acetaminophen / oxycodone)
- Klonopin (clonazepam)
- metformin
- Restoril (temazepam)
- tramadol
- Zantac (ranitidine)
Relagesic alcohol/food interactions
There is 1 alcohol/food interaction with Relagesic (acetaminophen / phenyltoloxamine).
Relagesic disease interactions
There are 7 disease interactions with Relagesic (acetaminophen / phenyltoloxamine) which include:
More about Relagesic (acetaminophen / phenyltoloxamine)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: analgesic combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.